ARTICLE SUMMARY:
Medtronic aims to prove that RDN can do more than lower blood pressure; NVIDIA's David Niewolny on supplying medtechs with computational powers that enable them to build out surgical AI; New approaches for AAAs; Stryker buys Amplitude Vascular to grow peripheral vascular division; from Market Pathways: should generative AI tools be trained, evaluated, and monitored like doctors as an alternative to regulatory oversight? Plus profiles of Entirety Biomedical and Urologic Health.
